Total Payments
$5,848
2024 Payments
$20.98
Companies
54
Transactions
414
Medicare Patients
2,694
Medicare Billing
$264,675
Payment Breakdown by Category
Food & Beverage$5,560 (95.1%)
Education$287.78 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,560 | 403 | 95.1% |
| Education | $287.78 | 11 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $781.37 | 57 | $0 (2022) |
| Genentech USA, Inc. | $764.99 | 64 | $0 (2022) |
| Amgen Inc. | $553.77 | 37 | $0 (2022) |
| PFIZER INC. | $410.23 | 35 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $390.85 | 31 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $237.83 | 18 | $0 (2020) |
| Astellas Pharma US Inc | $184.73 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $169.65 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $163.42 | 10 | $0 (2021) |
| Incyte Corporation | $159.48 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.98 | 1 | Lilly USA, LLC ($20.98) |
| 2023 | $143.28 | 3 | Astellas Pharma US Inc ($122.15) |
| 2022 | $487.83 | 26 | Amgen Inc. ($51.15) |
| 2021 | $178.96 | 11 | Amgen Inc. ($34.15) |
| 2020 | $388.94 | 20 | Amgen Inc. ($144.14) |
| 2019 | $934.12 | 64 | PFIZER INC. ($123.30) |
| 2018 | $1,796 | 136 | Novartis Pharmaceuticals Corporation ($266.47) |
| 2017 | $1,898 | 153 | Genentech USA, Inc. ($424.77) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 01/25/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ONCOLOGY | ||||||
| 01/12/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Oncology | ||||||
| 12/15/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: BioOncology | ||||||
| 12/02/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ONC | ||||||
| 11/22/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Hematology | ||||||
| 11/17/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Hematology | ||||||
| 11/03/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Oncology | ||||||
| 11/02/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 10/25/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2022 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Monoclonal Antibody | ||||||
| 10/14/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/12/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 10/06/2022 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, Phesgo | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: BioOncology | ||||||
| 09/27/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
| 09/20/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $28.11 | General |
| 09/12/2022 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $11.66 | General |
| 08/25/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2022 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI, MONJUVI | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Oncology | ||||||
| 07/21/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 545 | 863 | $155,841 | $55,497 |
| 2022 | 6 | 660 | 1,040 | $151,465 | $67,147 |
| 2021 | 8 | 794 | 1,224 | $140,671 | $83,089 |
| 2020 | 7 | 695 | 1,141 | $119,730 | $58,941 |
Total Patients
2,694
Total Services
4,268
Medicare Billing
$264,675
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 157 | 297 | $57,024 | $21,360 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 291 | 394 | $51,614 | $16,900 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 65 | 140 | $39,900 | $14,664 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $6,103 | $2,244 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 15 | 15 | $1,200 | $330.60 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 201 | 371 | $58,536 | $26,061 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 322 | 441 | $45,343 | $18,677 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 84 | 172 | $38,900 | $18,337 | 47.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 22 | 22 | $6,263 | $3,156 | 50.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 19 | $1,475 | $574.05 | 38.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 15 | 15 | $948.00 | $341.70 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 219 | 412 | $49,494 | $29,898 | 60.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 337 | 477 | $36,751 | $21,595 | 58.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 106 | 185 | $31,189 | $20,185 | 64.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 51 | 51 | $12,651 | $6,880 | 54.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 25 | 25 | $4,847 | $2,288 | 47.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 17 | $2,273 | $963.22 | 42.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 30 | $2,320 | $909.00 | 39.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 25 | 27 | $1,146 | $371.80 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 182 | 383 | $43,821 | $21,959 | 50.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 349 | 540 | $39,768 | $18,779 | 47.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 44 | 83 | $13,525 | $7,139 | 52.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 41 | 41 | $9,966 | $5,218 | 52.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 47 | 47 | $8,902 | $4,202 | 47.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 15 | 27 | $1,888 | $857.49 | 45.4% |
About Dr. John Hill, MD
Dr. John Hill, MD is a Hematology & Oncology healthcare provider based in Hendersonville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780646992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hill, MD has received a total of $5,848 in payments from pharmaceutical and medical device companies, with $20.98 received in 2024. These payments were reported across 414 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($5,560).
As a Medicare-enrolled provider, Hill has provided services to 2,694 Medicare beneficiaries, totaling 4,268 services with total Medicare billing of $264,675. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Hendersonville, NC
- Active Since 04/04/2006
- Last Updated 10/26/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780646992
Products in Payments
- Avastin (Biological) $259.35
- OPDIVO (Biological) $212.02
- KEYTRUDA (Biological) $191.06
- AFINITOR (Drug) $170.92
- JADENU (Drug) $168.14
- Perjeta (Biological) $148.16
- TASIGNA (Drug) $143.33
- IBRANCE (Drug) $139.74
- JAKAFI (Drug) $138.36
- Nplate (Biological) $129.13
- VENCLEXTA (Biological) $123.78
- Cabometyx (Drug) $118.90
- Kyprolis (Biological) $118.39
- KISQALI (Drug) $116.19
- ZEJULA (Drug) $111.84
- DARZALEX (Biological) $102.47
- Venclexta (Drug) $100.04
- Revlimid (Drug) $97.87
- Neulasta (Biological) $96.33
- SUTENT (Drug) $95.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Hendersonville
Don Jackson, Md, MD
Hematology & Oncology — Payments: $9,409
Hematology & Oncology $9,409
Dr. Douglas Thompson, M.d, M.D
Hematology & Oncology — Payments: $4,629
Hematology & Oncology $4,629
Dr. James Radford, Md, MD
Hematology & Oncology — Payments: $4,215
Hematology & Oncology $4,215
Laura Mcclure Barnes, M.d, M.D
Hematology & Oncology — Payments: $3,802
Hematology & Oncology $3,802
Mr. Alexander Tremont, Do, DO
Hematology & Oncology — Payments: $1,661
Hematology & Oncology $1,661
Dr. William Butler, Md, MD
Hematology & Oncology — Payments: $1,483
Hematology & Oncology $1,483